Suchergebnisse - "Zenz, Thorsten"

PubPharm (334)

71

IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

enthalten in: Nature communications | 2020

von Nadeu, F. | Mas-de-Les-Valls, R. | Navarro, A. | +19

72

Stellenwert der BRAF-Inhibition bei der Haarzellleukämie

enthalten in: Der Onkologe | 2020

von Rösler, W. | Zenz, T.

73

Stellenwert der BRAF-Inhibition bei der Haarzellleukämie

enthalten in: Der Onkologe | 2020

von Rösler, W. | Zenz, T.

74

BRAF inhibitor treatment in classic hairy cell leukemia : a long-term follow-up study of patients treated outside clinical trials

enthalten in: Leukemia | 2020

von Liebers, N. | Roider, T. | Bohn, J. | +13

75

Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy

enthalten in: Haematologica | 2020

von Ring, A. | Zenz, T.

CommentOn: Haematologica. 2020 May;105(5):1379-1390. - PMID 31467127

76

Mutated SF3B1 is associated with transcript isoform changes of the genes UQCC and RPL31 both in CLLs and uveal melanomas

enthalten in: bioRxiv.org | 2020

von Reyes, A. | Blume, C. | Pelechano, V. | +4

77

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

enthalten in: Haematologica | 2020

von Griggio, V. | Vitale, C. | Todaro, M. | +23

CommentIn: Haematologica. 2020 Apr;105(4):856-858. - PMID 32238465

78

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

enthalten in: Genome medicine | 2020

von Wierzbinska, J. | Toth, R. | Ishaque, N. | +17

79

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

enthalten in: Genome medicine | 2020

von Wierzbinska, J. | Toth, R. | Ishaque, N. | +17

80

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

enthalten in: Genome medicine | 2020

von Wierzbinska, J. | Toth, R. | Ishaque, N. | +17